CHH vs. Achondroplasia: What Is The Difference?
At a Glance
Cartilage-hair hypoplasia (CHH) and achondroplasia are two different genetic conditions that both cause short stature. While achondroplasia primarily affects bone growth, CHH is a more complex condition that also impacts the immune system, hair development, and digestive tract.
In this answer
4 sections
No, cartilage-hair hypoplasia (CHH) is not the same thing as achondroplasia. While both conditions cause short stature (a characteristic often referred to as dwarfism), they are completely distinct medical diagnoses with different genetic causes, bodily impacts, and medical needs. A definitive diagnosis is typically confirmed through genetic testing to ensure the correct care plan is established [1][2].
Achondroplasia is the most common type of dwarfism and primarily affects how bones grow [2]. In contrast, CHH is a more complex, multi-system condition that not only affects bone growth but also impacts the immune system, hair development, and sometimes the digestive tract [1][3].
Quick Comparison
| Feature | Achondroplasia | Cartilage-Hair Hypoplasia (CHH) |
|---|---|---|
| Gene Affected | FGFR3 [2] | RMRP [1] |
| Biological Process | Bone growth inhibition [2] | Cell division/ribosome function [2] |
| Primary Impacts | Skeleton, spine, ENT [4] | Skeleton, immune system, hair, digestion, blood [1][5] |
| Key Specialists | Orthopedist, Neurologist | Immunologist, Hematologist, Gastroenterologist |
Different Genetic Causes
The root cause of each condition lies in different genes and biological processes.
- Achondroplasia is caused by mutations in the FGFR3 gene [2]. This gene provides instructions for making a protein that regulates bone growth. In achondroplasia, the gene is overactive, which slows down the formation of bone from cartilage, leading to shorter limbs [2].
- CHH is caused by mutations in the RMRP gene [1]. This condition is classified as a ribosomopathy [2]. Ribosomes are the cell’s factories for making proteins. When the RMRP gene does not work correctly, it disrupts normal cell division and growth throughout the entire body, not just in the bones [6].
How They Affect the Body Differently
Because CHH impacts basic cellular function across the body, its effects are much broader than those of achondroplasia.
Achondroplasia: Primarily Bone and Structural
Achondroplasia primarily affects the skeleton, causing a specific type of short stature with shorter arms and legs (rhizomelic shortening) [2]. The medical challenges associated with achondroplasia are usually related to bone structure, such as narrowing of the spine or compression of the spinal cord at the base of the skull, as well as ear, nose, and throat issues [4]. It does not typically cause problems with the immune system or increase the risk of cancer [2].
CHH: A Multi-System Condition
CHH affects the skeleton differently, causing irregular and widened ends of the bones (metaphyseal dysplasia) [1]. Practically, this can lead to joint deformities, such as bowed legs, and unusual flexibility in the joints [1].
More importantly, your care team will monitor for and manage impacts on several other body systems:
- Immune System: Many people with CHH have a weakened immune system (immunodeficiency) because their bodies struggle to produce enough infection-fighting white blood cells (T-cells) [1][7]. While this can make individuals more prone to frequent or severe infections, immunologists have established protocols—such as preventative antibiotics or immune therapies—to help protect and manage your child’s health.
- Hair: A hallmark of CHH is very fine, sparse, and light-colored hair, eyebrows, and eyelashes (hypotrichosis) [1][5].
- Digestive System: Some children with CHH are born with a condition called Hirschsprung disease, where missing nerve cells in the intestines cause severe blockages and bowel issues [3]. This is typically identified and treated early in life.
- Blood and Cancer Risks: People with CHH have a higher risk of developing certain blood disorders, like anemia, and an increased risk of developing specific cancers later in life, such as lymphomas and cancers related to viral infections [8][9][10]. Regular monitoring and routine screening by a coordinated care team are key to identifying and managing these risks proactively.
Why the Distinction Matters
Understanding the difference is critical because the medical care required for CHH is much more involved than simply managing bone growth. While a child with achondroplasia will primarily see orthopedic and neurological specialists, a child with CHH requires a coordinated care team that includes an immunologist, a hematologist (blood specialist), and a gastroenterologist (digestive specialist) to monitor and protect their overall health over their lifetime.
Common questions in this guide
Is cartilage-hair hypoplasia the same as achondroplasia?
What causes cartilage-hair hypoplasia compared to achondroplasia?
What kind of doctors treat a child with cartilage-hair hypoplasia?
Does cartilage-hair hypoplasia affect the immune system?
Questions for Your Doctor
5 questions
- •Have genetic tests definitively confirmed the diagnosis as CHH, and has achondroplasia been fully ruled out?
- •Which specific specialists—such as an immunologist, hematologist, or gastroenterologist—should we consult with immediately to establish a comprehensive care team?
- •What does a routine screening schedule look like to monitor my child's immune system function and blood health?
- •Are there any preventative treatments, like prophylactic antibiotics or immunizations, that my child needs right now?
- •What specific signs of infection or digestive trouble should prompt an immediate call to your office or a visit to the emergency room?
Questions for You
3 questions
- •What specific physical characteristics or symptoms first led you to seek a medical evaluation?
- •Have you noticed any history of frequent, unusually severe, or prolonged infections in your child?
- •Are there any signs of digestive discomfort, such as severe chronic constipation or feeding difficulties, that you need to mention to the doctor?
References
References (10)
- 1
The Finnish founder mutation c.70 A>G in RMRP causes cartilage-hair hypoplasia in a Pakistani family.
Iqbal M, Muhammad N, Ali SA, et al.
Clinical dysmorphology 2017; (26(2)):121-123 doi:10.1097/MCD.0000000000000155.
PMID: 27740950 - 2
RMRP variants inhibit the cell cycle checkpoints pathway in cartilage‑hair hypoplasia.
Gao J, Zheng J, Chen S, et al.
Molecular medicine reports 2025; (31(3)).
PMID: 39886981 - 3
Cartilage-hair hypoplasia associated with isolated hypoganglionosis: A case report.
Yasui Y, Kohno M, Nishida S, et al.
Congenital anomalies 2017; (57(1)):32-34 doi:10.1111/cga.12175.
PMID: 27270827 - 4
[Cartilage-hair hypoplasia. A case report].
Staines-Boones TA, González-Villarreal MG, Hernández-Fernández C
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(3)):379-383 doi:10.29262/ram.v66i3.561.
PMID: 31606024 - 5
Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia.
Scott EM, Chandra S, Li J, et al.
Journal of clinical immunology 2020; (40(2)):321-328 doi:10.1007/s10875-019-00739-9.
PMID: 31903518 - 6
Rmrp Mutation Disrupts Chondrogenesis and Bone Ossification in Zebrafish Model of Cartilage-Hair Hypoplasia via Enhanced Wnt/β-Catenin Signaling.
Sun X, Zhang R, Liu M, et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019; (34(11)):2101-2116 doi:10.1002/jbmr.3820.
PMID: 31237961 - 7
A Wide Spectrum of Autoimmune Manifestations and Other Symptoms Suggesting Immune Dysregulation in Patients With Cartilage-Hair Hypoplasia.
Vakkilainen S, Mäkitie R, Klemetti P, et al.
Frontiers in immunology 2018; (9()):2468 doi:10.3389/fimmu.2018.02468.
PMID: 30410491 - 8
A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia.
Vakkilainen S, Taskinen M, Klemetti P, et al.
Frontiers in immunology 2019; (10()):1581 doi:10.3389/fimmu.2019.01581.
PMID: 31379817 - 9
Lymphomas in cartilage-hair hypoplasia - A case series of 16 patients reveals advanced stage DLBCL as the most common form.
Kukkola HL, Utriainen P, Huttunen P, et al.
Frontiers in immunology 2022; (13()):1004694 doi:10.3389/fimmu.2022.1004694.
PMID: 36211439 - 10
Refractory/Relapsed Hodgkin Lymphoma in Cartilage Hair Hypoplasia-Anauxetic Dysplasia Spectrum: Long-term HSCT-free Remission in 2 Pediatric Siblings.
Bukhari SI, Yazdani S, Fadoo Z
Journal of pediatric hematology/oncology 2026; (48(2)):e91-e96 doi:10.1097/MPH.0000000000003158.
PMID: 41460196
This page compares cartilage-hair hypoplasia and achondroplasia for educational purposes only. Always consult a geneticist or specialized medical team for an accurate diagnosis and appropriate care plan for your child.
Get notified when new evidence is published on Cartilage-hair hypoplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.